# The Safety and Pharmacokinetics of Intraperitoneal Administration in Patients Undergoing Appendectomy for Uncomplicated Appendicitis

> **NCT03046758** · PHASE2 · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 14 (actual)

## Conditions studied

- Appendicitis

## Interventions

- **DRUG:** A combination of fosfomycin, metronidazole and GM-CSF i.p.

## Key facts

- **NCT ID:** NCT03046758
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-24
- **Primary completion:** 2017-12-07
- **Final completion:** 2017-12-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-05-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03046758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03046758, "The Safety and Pharmacokinetics of Intraperitoneal Administration in Patients Undergoing Appendectomy for Uncomplicated Appendicitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03046758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*